Journal of South Asian Federation of Obstetrics and Gynaecology

Register      Login

VOLUME 12 , ISSUE 1 ( January-February, 2020 ) > List of Articles

Original Article

Serum Lipid Profile in Second Trimester as a Predictor of Gestational Hypertension

Aparna Rajesh, Anupama Suresh, Vandana Muralidharan

Citation Information : Rajesh A, Suresh A, Muralidharan V. Serum Lipid Profile in Second Trimester as a Predictor of Gestational Hypertension. J South Asian Feder Obs Gynae 2020; 12 (1):23-26.

DOI: 10.5005/jp-journals-10006-1750

License: CC BY-NC 4.0

Published Online: 02-11-2020

Copyright Statement:  Copyright © 2020; The Author(s).


Aim: To determine serum lipid profile early in second trimester of antenatal women and to study whether antenatal women with abnormal lipid profile in 2nd trimester are prone to develop gestational hypertension or preeclampsia and to determine whether dyslipidemia can be used as a marker in predicting PIH. The study is done to evaluate relationship between serum lipid concentrations and risk of preeclampsia. Materials and methods: Serum lipid profile was measured enzymatically by standardized assay in 90 pregnant women between 14 weeks and 20 weeks of gestation. Results were measured in terms of pregnancy induced hypertension. Out of these total number, 12 subjects developed PIH (study group), while 69 subjects remained normotensive (control group). Results: Out of these total number, 12 subjects developed PIH (study group), while 69 subjects remained normotensive (control group). The mean serum total cholesterol (TC) level was 233.25 mg/dL with p value <0.001, triglycerides (TG), and low-density lipoprotein cholesterol (LDL-C) was significantly higher in PIH women as compared to normotensive pregnant women. PIH women showed no significant change in high-density lipoprotein cholesterol (HDL-C) level and very low-density lipoprotein cholesterol (VLDL-C) to normal pregnant women. Conclusion: Serum lipid level in early pregnancy is a very good noninvasive method to predict the of PIH before the clinical onset.

  1. Cunningham FG, Leveno KJ, Bloom SL, et al. Pregnancy hypertension. In: Kenneth J, et al. Williams obsterics. 23. New York: McGraw-Hill; 2010. p. 706.
  2. Powers RW, Bodnar LM, Ness RB, et al. Uric acid concentrations in early pregnancy among preeclamptic women with gestational hyperuricemia at delivery. Am J Obstet Gynecol 2006;194(1):160. DOI: 10.1016/j.ajog.2005.06.066.
  3. Robson SC. Hypertension and renal disease in pregnancy. In: Edmonds DK. Dewhurst's Textbook of Obstetrics and Gynaecology for postgraduates. 6th edn., New York: Blackwell Science; 1999. pp. 167–169.
  4. Singh U, Yadav S, Mehrotra S, et al. Serum lipid profile in early pregnancy as a predictor of preeclampsia. Int J Med Res Rev 2013;1(2):56–62. DOI: 10.17511/ijmrr.2013.i02.03.
  5. Vidyabharathi RK, Davina H, Singh NK, et al. Serum beta hCG and lipid profile in second trimester as predictors of pregnancy induced hypertension. J Obstet Gynecol India 2010;60:44–50.
  6. Kaur G, Jain V, Mehta S, et al. Prediction of PIH by maternal serum beta hCG levels in the second trimester of pregnancy. J Obstet Gynaecol India 2012;62(1):52–54. DOI: 10.1007/s13224-012-0151-y.
  7. Anuradha R, Durga T. Estimation of lipid profile among preeclamsia women by comparing with pregnancy. Int J Med Res Rev 2016;3(7):2454–7379.
  8. Deshpande H, Chandrakanth M, Poona MV, et al. Study of serum lipid profile pregnancy induced hypertension. Indian J Appl Res 2016;6:546–548.
  9. Enquobahrie DA, Williams MA, Butler CL, et al. Maternal plasma lipid concentrations in early pregnancy and risk of preeclampsia. Am J Hypertens 2004;17(7):574–581. DOI: 10.1016/j.amjhyper.2004.03.666.
  10. Jameela Poonmalar Ar, Jesuthangam M, Vishnupriya S. Materanal lipid during early pregnancy as predictor of pregnancy induced hypertension. Int J Gynecology 2019;9(3).
  11. Padma Leela K, Rama Devi G, Neeraja M. Study of serum lipid profile in second trimester as predictor of hypertensive disorder complicating pregnancy. Int J Preclinical Pharmac Res 2012;3(2):114–117.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.